Eureka! We've found . . . out that we were awarded a grant from the National Institute on Drug Abuse (NIDA). In the coming year, using...

The SARS-CoV-2 coronavirus that causes COVID-19 disease is an enveloped virus. Meaning, it is mostly human plasma membrane, with a few...

Did you ever wonder: Hey, the original SARS outbreak was 15 years ago, why don’t we just use the SARS vaccine we put our (and every...

Necessity is said to be the mother of invention, but the jury is still out on the success of the desperate and rushed phenotypic screens...

While the protease inhibitor flopped for COVID-19, that doesn’t mean that the line of reasoning of drugs cross-reactive with viral...

A small pilot study from France showed that all six COVID-19 patients given a hydroxychloroquine/azithromycin combination recovered...

The early days of the COVID-19 pandemic have seen a rush to repurpose existing approved or near approval drugs, due to the urgency of the...

The massive inefficiency of target-based high-throughput screening eventually led to major pivots in the pharmaceutical industry. The...

In contrast to target-based strategies, phenotypic drug discovery does not rely on knowledge of a specific drug target or a hypothesis...

The truth wins out in the end. Time and again we have fallen in love with spectacular molecular techniques of drug discovery, but Mother...